Showing 441-450 of 2922 results for "".
A Breathtaking Evolution of Therapeutic Approaches
https://practicalneurology.com/diseases-diagnoses/movement-disorders/a-breathtaking-evolution-of-therapeutic-approaches/30237/Refractory Headache: Focus on the Patient
https://practicalneurology.com/diseases-diagnoses/headache-pain/PN0909_04-php/30890/Most patients want to get better, but any number of obstacles may interfere with recovery from pain.Neuroimaging Biomarkers in Alzheimer Disease and Related Dementias: From Structural MRI to Amyloid and Tau PET
https://practicalneurology.com/diseases-diagnoses/imaging-testing/neuroimaging-biomarkers-in-alzheimer-disease-and-related-dementias-from-structural-mri-to-amyloid-and-tau-pet/56376/This practical guide explains how multimodal neuroimaging refines the diagnosis of Alzheimer disease, frontemporal dementia, dementia with Lewy bodies, and vascular dementia.A Choreographed Approach to the Treatment of Chorea
https://practicalneurology.com/diseases-diagnoses/movement-disorders/a-choreographed-approach-to-the-treatment-of-chorea/32166/The treatment approach to chorea benefits from individualized patient considerations and multidisciplinary methodology.Diagnosis of Chronic Inflammatory Demyelinating Polyneuropathy
https://practicalneurology.com/diseases-diagnoses/neuromuscular/diagnosis-of-chronic-inflammatory-demyelinating-polyneuropathy/32112/Due to the heterogeneous presentation of this complex disease, diagnosis is not always straightforward, and proper interpretation of clinical and diagnostic data is crucial to avoid misdiagnosis.The Many Faces of Facioscapulohumeral Muscular Dystrophy
https://practicalneurology.com/diseases-diagnoses/neuromuscular/the-many-faces-of-facioscapulohumeral-muscular-dystrophy/56910/Facioscapulohumeral muscular dystrophy should be conceptualized not as a single entity, but as a spectrum disorder with a complex genetic basis.Movement Disorders Moment: Personalized Medicine in Parkinson Disease
https://practicalneurology.com/archives/aug-2025-issue/personalized-medicine-in-parkinson-disease/36699/Pharmacogenetic testing provides a promising path to personalizing treatments for individuals living with Parkinson disease.Digital Cognitive Assessments for Dementia
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/digital-cognitive-assessments-for-dementia/31728/Digital assessments may enhance the efficiency of evaluations in neurology and other clinics.- Building a better UPDRShttps://practicalneurology.com/columns/practice-management/building-a-better-updrs/31010/Since the late 1980s, the Unified Parkinson’s Disease Rating Scale (UPDRS) has been a cornerstone in assessing Parkinson’s Disease (PD), primarily focusing on motor symptoms such as finger tapping, fist opening, and rising from a chair. However, over the past two decades, advancements in PD research
Biomarkers in Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/imaging-testing/biomarkers-in-multiple-sclerosis/30195/Biomarkers have resulted from breakthrough treatments and, in turn, provide targets for more breakthroughs.